| Reaction Details |
|---|
 | Report a problem with these data |
| Target | L-lactate dehydrogenase B chain |
|---|
| Ligand | BDBM23251 |
|---|
| Substrate/Competitor | BDBM23233 |
|---|
| Meas. Tech. | Lactate Dehydrogenase Inhibition Assay |
|---|
| IC50 | 10270±n/a nM |
|---|
| Citation |  Cameron, A; Read, J; Tranter, R; Winter, VJ; Sessions, RB; Brady, RL; Vivas, L; Easton, A; Kendrick, H; Croft, SL; Barros, D; Lavandera, JL; Martin, JJ; Risco, F; García-Ochoa, S; Gamo, FJ; Sanz, L; Leon, L; Ruiz, JR; Gabarró, R; Mallo, A; Gómez de las Heras, F Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity. J Biol Chem279:31429-39 (2004) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Solution Info, Assay Method |
|---|
| |
| L-lactate dehydrogenase B chain |
|---|
| Name: | L-lactate dehydrogenase B chain |
|---|
| Synonyms: | L-lactate dehydrogenase B | L-lactate dehydrogenase B chain | LDH heart subunit | LDH-B | LDH-H | LDHB | LDHB_HUMAN | Lactate dehydrogenase B (LDHB) | Renal carcinoma antigen NY-REN-46 |
|---|
| Type: | Oxidoreductase; homotetramer |
|---|
| Mol. Mass.: | 36635.55 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 334 |
|---|
| Sequence: | MATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLK
GEMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKF
IIPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLG
IHPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAY
EVIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARG
LTSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL
|
|
|
|---|
| BDBM23251 |
|---|
| BDBM23233 |
|---|
| Name | BDBM23251 |
|---|
| Synonyms: | 1,2,5-Thiadiazole, TDA1 | 4-hydroxy-1,2,5-thiadiazole-3-carboxylic acid | LDHA Inhibitor, 1 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C3H2N2O3S |
|---|
| Mol. Mass. | 146.125 |
|---|
| SMILES | OC(=O)c1ns[nH]c1=O |
|---|
| Structure | 
|
|---|
Search and Browse
